Press "Enter" to skip to content

Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study

Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study
To study the effects of metformin treatment on bone turnover in women with polycystic ovary syndrome (PCOS), as measured by serum concentrations of bone turnover markers.
Source: fertstert.org

Be First to Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.